La bourse est fermée

Bayer Aktiengesellschaft (BAYN.DE)

XETRA - XETRA Prix différé. Devise en EUR
Ajouter à la liste dynamique
64,47+0,73 (+1,15 %)
À la clôture : 05:43PM CEST

Bayer Aktiengesellschaft

Kaiser-Wilhelm-Allee 1
Leverkusen 51368
Germany
49 214 30 1
https://www.bayer.com

Secteur(s)Healthcare
Secteur d’activitéDrug Manufacturers—General
Employés à temps plein100 753

Dirigeants clés

NomTitrePayerExercéAnnée de naissance
Mr. Werner BaumannChairman of Management Board, CEO & Chief Sustainability Officer5,7MS.O.1962
Mr. Wolfgang U. NicklCFO & Member of Management Board2,25MS.O.1969
Mr. Heiko W. J. SchipperMember of Management Board & Pres of the Consumer Health Division2,43MS.O.1969
Mr. Stefan OelrichHead of the Pharmaceuticals Division & Member of the Board of Management3,01MS.O.1968
Ms. Sarena S. LinChief Transformation & Talent Officer, Labor Director and Member of Management Board3,17MS.O.1971
Mr. Rodrigo SantosMember of Management Board & Pres of the Crop Science DivisionS.O.S.O.1973
Mr. Bernd-Peter BierHead of Accounting and Head of TaxesS.O.S.O.1967
Mr. Oliver MaierHead of Investor RelationsS.O.S.O.S.O.
Dr. Gabriel HarnierHead of Law, Patents & ComplianceS.O.S.O.1971
Mr. Michael PreussHead of Communications, Gov. Relations and Corp. BrandS.O.S.O.S.O.
Les montants ont été établis en date du 31 décembre 2021 et les valeurs de compensation concernent le dernier exercice fiscal clos à cette date. Le terme « rémunération » désigne le salaire, les bonus, etc. Le terme « exercé » est utilisé pour la valeur des options exercées au cours de l’exercice fiscal. Devise exprimée en EUR.

Description

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, medicated skincare products, nutritional supplements, and self-care solutions in dermatology, nutritional supplements, pain and cardiovascular risk prevention, digestive health, allergy, and cold and cough. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solution, and pest and weed control products, as well as customer service for agriculture. This segment also provides breeding, propagation, and production/processing of seeds, including seed dressing. The company has a collaboration agreement with MD Anderson Cancer Center to develop oncology drugs; research and license agreement with Dewpoint Therapeutics, Inc. for the development of new treatments for cardiovascular and gynecological diseases; collaboration agreement with Exscientia Ltd, Foundation Medicine Inc., and Evotec AG; research collaboration with Arvinas Inc.; strategic research partnership with University of Oxford to develop novel gynecological therapies; and Kyoto University to identify new drugs candidates for the treatment of pulmonary diseases. It distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. Bayer Aktiengesellschaft was founded in 1863 and is headquartered in Leverkusen, Germany.

Gouvernance d’entreprise

L’ISS Governance QualityScore de Bayer Aktiengesellschaft en date du 1 mai 2022 est 4. Les scores principaux sont Audit : 2; Société : 3; Droits des actionnaires : 1; Compensation : 8.

Résultats de gouvernance d’entreprise offerts par Institutional Shareholder Services (ISS). Les résultats indiquent un rang décile par rapport à l’indice ou à la région. Un résultat décile de 1 indique un risque de gouvernance faible, tandis que 10 indique un risque de gouvernance élevé.